GOSS vs PTC · rev $26.2M vs P/E 48, rev $2.74B
Gossamer Bio Inc (GOSS) versus PTC Inc (PTC) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
PTC Inc (PTC) is a software - application company listed on US.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
GOSS currently screens at market cap $47.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Not investment advice. Open the GOSS and PTC stock pages for the full models.
Not investment advice.